Claims, checked against the paper
A summit is a claim. We show you the data points.
We re-read the studies the peptide market is citing and grade what they can actually support — starting with the claims on the catalog we point you to.
5
59
3
Latest · Audit
The COA They Sent You Is Real. That Doesn't Mean It's About Your Vial.
Five fields decide whether a certificate of analysis describes the vial in your hand or one somebody tested once, two years ago — and you can check all five in thirty seconds.
MTMartin ThomasRead audit →
Compound deep dive · BPC-157
BPC-157 Isn't "Only Rat Studies." It's Tier 2, and That's the Argument You Should Be Having.
The claim everyone repeats is factually wrong and directionally right — here's the evidence ladder that settles it in one question.
Compound deep dive · BPC-157
BPC-157 and TB-500 Do Different Things on Paper. The Blend Ratio Is Still Somebody's Guess.
Two distinct proposed mechanisms, one shared evidence ceiling — and no published study that tested the pair against either compound alone.
Compound deep dive · CJC-1295
Your COA Says 99.9%. That Number Can Be True and the Vial Still Be Short.
Purity tells you the composition of what's in the vial. It says nothing about how much is in there — and almost every certificate published to buyers answers the first question and quietly skips the second.
One audit a month. No product emails.
We re-read a study everybody is citing and say what it can actually support — including when the answer costs us a sale.